International Immunology, Vol. 12, No. 4, 439-448,
April 2000
© 2000 Japanese Society for Immunology
Molecular cloning and characterization of mouse CD97
Department of Immunobiology, CLB and Laboratory for Experimental and Clinical Immunology, Academic Medical Centre, University of Amsterdam, Plesmanlaan 125, 1066 CX Amsterdam, The Netherlands
Correspondence to: J. Hamann
The EGF-TM7 family (CD97 and EMR1) is a group of class II seven-span transmembrane receptors predominantly expressed by cells of the immune system. Recently, we have identified CD55, a regulatory molecule of the complement cascade, as a cellular ligand of human CD97 (hCD97). In this study, the molecular properties of mouse CD97 (mCD97) are described. Like hCD97, mCD97 has an extended extracellular region with several epidermal growth factor-like (EGF) domains. Due to alternative RNA splicing, isoforms with three and four EGF domains exist, designated mCD97(EGF1,2,4) and mCD97(EGF1,2,3,4) respectively. All EGF domains, except for the N-terminal one, possess a calcium-binding site. In a third isoform mCD97(EGF1,2,X,3,4), a sequence of 45 amino acids was found between the second and third EGF domain that does not correspond to any known protein module. Using newly generated mCD97 mAb, we show that analogous to the blood expression pattern of hCD97, mCD97 can be found on lymphoid and myeloid cells. Adhesion of mouse erythrocytes and splenocytes to COS cells expressing mCD97(EGF1,2,4) or mCD97(EGF1,2,3,4) could be blocked by mouse CD55 (mCD55) antibody, identifying mCD55 as a cellular ligand for mCD97. Consistent with the necessity of directly linked EGF domains for the integrity of the CD55-binding site on hCD97, no adhesion was detected to the largest mouse isoform mCD97(EGF1,2,X,3,4). Remarkably, we found that the interaction between CD97 and CD55 is phylogenetically restricted, as indicated by the selective adhesion of primate erythrocytes to hCD97 transfectants, and of mouse and rat erythrocytes to mCD97 transfectants respectively.
Keywords: adhesion, CD55, cDNA cloning, EGF-TM7 family, G protein-coupled receptors, phylogenetic restriction
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. M. de Groot, G. Vogel, J. Dulos, L. Teeuwen, K. Stebbins, J. Hamann, B. M. Owens, H. van Eenennaam, E. Bos, and A. M. Boots Therapeutic Antibody Targeting of CD97 in Experimental Arthritis: the Role of Antigen Expression, Shedding, and Internalization on the Pharmacokinetics of Anti-CD97 Monoclonal Antibody 1B2 J. Immunol., September 15, 2009; 183(6): 4127 - 4134. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Veninga, S. Becker, R. M. Hoek, M. Wobus, E. Wandel, J. van der Kaa, M. van der Valk, A. F. de Vos, H. Haase, B. Owens, et al. Analysis of CD97 Expression and Manipulation: Antibody Treatment but Not Gene Targeting Curtails Granulocyte Migration J. Immunol., November 1, 2008; 181(9): 6574 - 6583. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. van Pel, H. Hagoort, J. Hamann, and W. E. Fibbe CD97 is differentially expressed on murine hematopoietic stem-and progenitor-cells Haematologica, August 1, 2008; 93(8): 1137 - 1144. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. van Pel, H. Hagoort, M. J. Kwakkenbos, J. Hamann, and W. E. Fibbe Differential role of CD97 in interleukin-8-induced and granulocyte-colony stimulating factor-induced hematopoietic stem and progenitor cell mobilization Haematologica, April 1, 2008; 93(4): 601 - 604. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pridans, M. L. Holmes, M. Polli, J. M. Wettenhall, A. Dakic, L. M. Corcoran, G. K. Smyth, and S. L. Nutt Identification of Pax5 Target Genes in Early B Cell Differentiation J. Immunol., February 1, 2008; 180(3): 1719 - 1728. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wang, L. Tian, M. Haino, J.-L. Gao, R. Lake, Y. Ward, H. Wang, U. Siebenlist, P. M. Murphy, and K. Kelly Improved Antibacterial Host Defense and Altered Peripheral Granulocyte Homeostasis in Mice Lacking the Adhesion Class G Protein Receptor CD97 Infect. Immun., March 1, 2007; 75(3): 1144 - 1153. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Matmati, W. Pouwels, R. van Bruggen, M. Jansen, R. M. Hoek, A. J. Verhoeven, and J. Hamann The human EGF-TM7 receptor EMR3 is a marker for mature granulocytes J. Leukoc. Biol., February 1, 2007; 81(2): 440 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Kwakkenbos, M. Matmati, O. Madsen, W. Pouwels, Y. Wang, R. E. Bontrop, P. J. Heidt, R. M. Hoek, and J. Hamann An unusual mode of concerted evolution of the EGF-TM7 receptor chimera EMR2 FASEB J, December 1, 2006; 20(14): 2582 - 2584. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wang, Y. Ward, L. Tian, R. Lake, L. Guedez, W. G. Stetler-Stevenson, and K. Kelly CD97, an adhesion receptor on inflammatory cells, stimulates angiogenesis through binding integrin counterreceptors on endothelial cells Blood, April 1, 2005; 105(7): 2836 - 2844. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Leemans, A. A. te Velde, S. Florquin, R. J. Bennink, K. de Bruin, R. A. W. van Lier, T. van der Poll, and J. Hamann The Epidermal Growth Factor-Seven Transmembrane (EGF-TM7) Receptor CD97 Is Required for Neutrophil Migration and Host Defense J. Immunol., January 15, 2004; 172(2): 1125 - 1131. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stacey, G.-W. Chang, J. Q. Davies, M. J. Kwakkenbos, R. D. Sanderson, J. Hamann, S. Gordon, and H.-H. Lin The epidermal growth factor-like domains of the human EMR2 receptor mediate cell attachment through chondroitin sulfate glycosaminoglycans Blood, October 15, 2003; 102(8): 2916 - 2924. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Schaller, A. J. Macfarlane, R. A. Rupec, S. Gordon, A. J. McKnight, and K. Pfeffer Inactivation of the F4/80 Glycoprotein in the Mouse Germ Line Mol. Cell. Biol., November 15, 2002; 22(22): 8035 - 8043. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stacey, G.-W. Chang, S. L. Sanos, L. R. Chittenden, L. Stubbs, S. Gordon, and H.-H. Lin EMR4, a Novel Epidermal Growth Factor (EGF)-TM7 Molecule Up-regulated in Activated Mouse Macrophages, Binds to a Putative Cellular Ligand on B Lymphoma Cell Line A20 J. Biol. Chem., August 2, 2002; 277(32): 29283 - 29293. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Kwakkenbos, G.-W. Chang, H.-H. Lin, W. Pouwels, E. C. de Jong, R. A. W. van Lier, S. Gordon, and J. Hamann The human EGF-TM7 family member EMR2 is a heterodimeric receptor expressed on myeloid cells J. Leukoc. Biol., May 1, 2002; 71(5): 854 - 862. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Caminschi, K. M. Lucas, M. A. O'Keeffe, H. Hochrein, Y. Laabi, F. Kontgen, A. M. Lew, K. Shortman, and M. D. Wright Molecular Cloning of F4/80-Like-Receptor, a Seven-Span Membrane Protein Expressed Differentially by Dendritic Cell and Monocyte-Macrophage Subpopulations J. Immunol., October 1, 2001; 167(7): 3570 - 3576. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stacey, H.-H. Lin, K. L. Hilyard, S. Gordon, and A. J. McKnight Human Epidermal Growth Factor (EGF) Module-containing Mucin-like Hormone Receptor 3 Is a New Member of the EGF-TM7 Family That Recognizes a Ligand on Human Macrophages and Activated Neutrophils J. Biol. Chem., May 25, 2001; 276(22): 18863 - 18870. [Abstract] [Full Text] [PDF] |
||||







